Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Depreciation & Amortization (CF) (2019 - 2025)

Historic Depreciation & Amortization (CF) for Benitec Biopharma (BNTC) over the last 7 years, with Q2 2025 value amounting to $14000.0.

  • Benitec Biopharma's Depreciation & Amortization (CF) fell 4615.38% to $14000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $66000.0, marking a year-over-year decrease of 2413.79%. This contributed to the annual value of $66000.0 for FY2025, which is 2413.79% down from last year.
  • Latest data reveals that Benitec Biopharma reported Depreciation & Amortization (CF) of $14000.0 as of Q2 2025, which was down 4615.38% from $13000.0 recorded in Q1 2025.
  • In the past 5 years, Benitec Biopharma's Depreciation & Amortization (CF) registered a high of $67000.0 during Q1 2021, and its lowest value of $6000.0 during Q2 2022.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $25500.0 (2024), whereas its average is $31944.4.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first crashed by 8846.15% in 2022, then soared by 25000.0% in 2023.
  • Quarter analysis of 5 years shows Benitec Biopharma's Depreciation & Amortization (CF) stood at $55000.0 in 2021, then fell by 25.45% to $41000.0 in 2022, then plummeted by 58.54% to $17000.0 in 2023, then fell by 17.65% to $14000.0 in 2024, then changed by 0.0% to $14000.0 in 2025.
  • Its last three reported values are $14000.0 in Q2 2025, $13000.0 for Q1 2025, and $14000.0 during Q4 2024.